(Q54474404)

30 May 2018

title

Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. (English)

1 reference

30 May 2018

1 reference

8

Masaaki Oka

1 reference

30 May 2018

author name string

Michiko Sato Tamesa

1

1 reference

30 May 2018

Yasuhiro Kuramitsu

2

1 reference

30 May 2018

Masanori Fujimoto

3

1 reference

30 May 2018

Noriko Maeda

4

1 reference

30 May 2018

Yukiko Nagashima

5

1 reference

30 May 2018

Toshiyuki Tanaka

6

1 reference

30 May 2018

Shigeru Yamamoto

7

1 reference

30 May 2018

Kazuyuki Nakamura

9

1 reference

30 May 2018

publication date

1 June 2009

1 reference

30 May 2018

published in

Electrophoresis

1 reference

30 May 2018

volume

30

1 reference

30 May 2018

issue

12

1 reference

30 May 2018

page(s)

2168-2181

1 reference

30 May 2018

Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Trends in breast cancer incidence, survival, and mortality.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

The immunology and immunotherapy of breast cancer: an update

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Clinical and biological significance of HSP89 alpha in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Role of HER2 gene overexpression in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Proteomic profiling for cancer progression: Differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Prolyl cis-trans isomerization as a molecular timer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Cyclophilin A is a secreted growth factor induced by oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

The role of prolactin in mammary carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Autoantibodies in breast cancer: their use as an aid to early diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800675

7 January 2021

Identifiers

DOI

10.1002/ELPS.200800675

1 reference

30 May 2018

1 reference

30 May 2018